Log In
Print this Print this

NasoShield (AdVAV anthrax vaccine)

  Manage Alerts
Collapse Summary General Information
Company Altimmune Inc.
DescriptionIntranasal recombinant protein antigen (rPA)-based vaccine
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationAnthrax
Indication DetailsPrevent anthrax infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today